Ordinary Shares SEC Reporting - Current
Verified Company Profile 9/22/2017
Contact Info
  • Suite 600 - 535 Howe Street
  • Vancouver, BC V6C 2Z4
  • Canada

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2017 Interim Financial Report
CIK 0001579026
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: Canada
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Alejandro Ochoa CEO
Octavio De La Espriella COO
Abbey Abdiye CFO
Company Directors
Brian Gusko Chairman
Fabio Alexander
Robert Horsely
Alejandro Ochoa
Company Notes
  • Formerly=Pacific Therapeutics Limited until 1-2017
Service Providers
Accounting/Auditing Firm
Manning Elliott LLP
1050 W. Pender Street
11th Floor
Vancouver, BC, V6E 3S7

Legal Counsel
Miller Thomson LLP
400 - 725 Granville Street
Vancouver, ONT, M5H 3S1

Investor Relations Firm
Not Available
TOWTF Security Details
Share Structure
Market Value1 $12,580,886 a/o Jan 19, 2018
Authorized Shares Unlimited a/o Sep 13, 2017
Outstanding Shares 63,862,365 a/o Sep 13, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value Not Available
Transfer Agent(s)
Shareholders of Record Not Available
Non US Stock Exchange Listing
TO - Canadian Securities Exchange - Qualified
Short Selling Data
Short Interest 13,485 (96%)
Dec 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security